rs147336902

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001128840.3(CACNA1D):​c.954G>A​(p.Ala318Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00512 in 1,614,136 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0052 ( 39 hom. )

Consequence

CACNA1D
NM_001128840.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.538

Publications

1 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.133).
BP6
Variant 3-53666373-G-A is Benign according to our data. Variant chr3-53666373-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226481.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.538 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00393 (599/152294) while in subpopulation NFE AF = 0.00637 (433/68020). AF 95% confidence interval is 0.00587. There are 4 homozygotes in GnomAd4. There are 273 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128840.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 49NP_000711.1Q01668-2
CACNA1D
NM_001128840.3
MANE Select
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 48NP_001122312.1Q01668-1
CACNA1D
NM_001128839.3
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 46NP_001122311.1Q01668-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 49ENSP00000288139.3Q01668-2
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 48ENSP00000288133.5Q01668-1
CACNA1D
ENST00000481478.2
TSL:1
c.954G>Ap.Ala318Ala
synonymous
Exon 7 of 49ENSP00000418014.2H0Y879

Frequencies

GnomAD3 genomes
AF:
0.00394
AC:
600
AN:
152176
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00637
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00412
AC:
1035
AN:
251416
AF XY:
0.00442
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00257
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00213
Gnomad NFE exome
AF:
0.00571
Gnomad OTH exome
AF:
0.00391
GnomAD4 exome
AF:
0.00524
AC:
7665
AN:
1461842
Hom.:
39
Cov.:
33
AF XY:
0.00536
AC XY:
3900
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33480
American (AMR)
AF:
0.00268
AC:
120
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00674
AC:
581
AN:
86256
European-Finnish (FIN)
AF:
0.00174
AC:
93
AN:
53420
Middle Eastern (MID)
AF:
0.00521
AC:
30
AN:
5754
European-Non Finnish (NFE)
AF:
0.00588
AC:
6533
AN:
1111982
Other (OTH)
AF:
0.00392
AC:
237
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
430
861
1291
1722
2152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00393
AC:
599
AN:
152294
Hom.:
4
Cov.:
33
AF XY:
0.00367
AC XY:
273
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41574
American (AMR)
AF:
0.00372
AC:
57
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5168
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4822
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10618
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00637
AC:
433
AN:
68020
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00524
Hom.:
1
Bravo
AF:
0.00347
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00600
EpiControl
AF:
0.00551

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
not specified (3)
-
-
1
Aldosterone-producing adenoma with seizures and neurological abnormalities (1)
-
-
1
CACNA1D-related disorder (1)
-
-
1
Sinoatrial node dysfunction and deafness;C3809609:Aldosterone-producing adenoma with seizures and neurological abnormalities (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Benign
0.84
PhyloP100
0.54
PromoterAI
-0.022
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147336902; hg19: chr3-53700400; API